ABT Operating Income Growth
Abbott Laboratories · Operating Income Growth
ABT Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported5.09%period ending
ABT TTM Operating Income YoY % (18.91% → 5.09%)
Year-over-year change
High-resolution chart · PNG
ABT operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 5.0874% | |
| 14.2022% | |
| 16.9937% | |
| 15.3117% | |
| 14.1388% | |
| 11.5564% | |
| 6.6016% | |
| 11.99% | |
| 9.2155% | |
| -6.3836% | |
| -22.8295% | |
| -35.6319% | |
| -41.1393% | |
| -30.8983% | |
| -9.1087% | |
| 2.1926% | |
| 28.5714% | |
| 49.7667% | |
| 73.8802% | |
| 114.0822% | |
| 98.6346% | |
| 45.2142% | |
| 16.1326% | |
| -1.04% | |
| -3.521% | |
| 16.3784% | |
| 18.5224% | |
| 27.1525% | |
| 28.1461% | |
| 45.6836% | |
| 95.9225% | |
| 54.5413% | |
| 47.088% | |
| 2.1188% | |
| -39.3133% | |
| -28.3436% | |
| -22.7685% | |
| -4.9622% | |
| 12.766% | |
| 6.6644% | |
| -1.0693% | |
| -2.3182% | |
| 10.1845% | |
| 13.8735% | |
| 27.5968% | |
| 28.1278% | |
| 5.2589% | |
| -38.7457% | |
| -42.7324% | |
| -43.0917% | |
| -34.9254% | |
| 19.1717% | |
| 5.772% | |
| -21.2741% | |
| -33.9523% | |
| -36.9723% | |
| -38.3587% | |
| -16.193% | |
| -5.527% | |
| -10.1745% | |
| -7.535% | |
| -10.9522% | |
| -2.3674% | |
| 0.117% | |
| 12.0868% | |
| 18.5321% | |
| 9.5143% | |
| 11.8069% | |
| 17.4474% | |
| 17.3266% | |
| 24.3592% | |
| 94.8587% | |
| 94.5709% | |
| 148.164% | |
| 124.1946% | |
| -21.972% | |
| -31.2756% | |
| -55.1194% | |
| -53.1845% | |
| -14.1675% | |
| -14.6959% | |
| 5.0573% | |
| 11.9012% | |
| 8.146% | |
| 19.3092% | |
| 31.5231% | |
| 24.3267% | |
| 32.7744% | |
| 21.9896% | |
| -10.4043% | |
| -11.1779% | |
| -13.0359% | |
| -5.5249% | |
| 11.7056% | |
| 86.3823% | |
| 59.63% | |
| 48.7658% | |
| 30.0622% | |
| -44.3026% | |
| -36.6494% |